James W. Patterson

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma

Gulsun Erdag, Jochen T. Schaefer, Mark E. Smolkin et al. · Cancer Research · 2012 · 614 citations · Full text

Medicine, Oncology, Pathology +17

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov et al. · Journal of Clinical Oncology · 2003 · 321 citations

Medicine, Immunology, Oncology +17

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese et al. · PubMed · 2001 · 229 citations

Medicine, Immunology, Oncology +17

Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.

S Poucell, JOHN IRETON, Pedro Valencia‐Mayoral et al. · PubMed · 1984 · 178 citations

Medicine, Pathobiology, Pathology +12

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock et al. · Clinical Cancer Research · 2007 · 163 citations · Full text

Medicine, Immunology, Oncology +17